Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.

Ooi EM, Ellis KL, Barrett PHR, Watts G, Hung J, Beilby JP, Thompson PL, Stobie P, McQuillan BM.

Atherosclerosis. 2018 Jun 18;275:232-238. doi: 10.1016/j.atherosclerosis.2018.06.863. [Epub ahead of print]

PMID:
29960898
2.

Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.

Chan DC, Watts GF, Somaratne R, Wasserman SM, Scott R, Barrett PHR.

Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1644-1655. doi: 10.1161/ATVBAHA.118.310882. Epub 2018 Jun 7.

3.

Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics.

Watts GF, Chan DC, Somaratne R, Wasserman SM, Scott R, Marcovina SM, Barrett PHR.

Eur Heart J. 2018 Jul 14;39(27):2577-2585. doi: 10.1093/eurheartj/ehy122.

PMID:
29566128
4.

Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women.

Lamon-Fava S, Diffenderfer MR, Barrett PHR, Wan WY, Postfai B, Nartsupha C, Dolnikowski GG, Schaefer EJ.

Lipids. 2018 Feb;53(2):167-175. doi: 10.1002/lipd.12011. Epub 2018 Mar 14.

PMID:
29537647
5.

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR+/- and LDLR-/-) Yucatan Miniature Pigs.

Burke AC, Telford DE, Sutherland BG, Edwards JY, Sawyez CG, Barrett PHR, Newton RS, Pickering JG, Huff MW.

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1178-1190. doi: 10.1161/ATVBAHA.117.310676. Epub 2018 Feb 15.

PMID:
29449335
6.

Acute Impact of Different Exercise Modalities on Arterial and Platelet Function.

Haynes A, Linden MD, Robey E, Watts GF, Barrett PHR, Naylor LH, Green DJ.

Med Sci Sports Exerc. 2018 Apr;50(4):785-791. doi: 10.1249/MSS.0000000000001505.

PMID:
29240651
7.

Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development.

Birzniece V, Barrett PHR, Ho KKY.

Eur J Endocrinol. 2017 Aug;177(2):137-143. doi: 10.1530/EJE-17-0151. Epub 2017 May 12.

8.

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Thongtang N, Diffenderfer MR, Ooi EMM, Barrett PHR, Turner SM, Le NA, Brown WV, Schaefer EJ.

J Lipid Res. 2017 Jul;58(7):1315-1324. doi: 10.1194/jlr.M073882. Epub 2017 Apr 9.

9.

Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.

Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, Ståhlman M, Adiels M, Hakkarainen A, Lundbom N, Kilicarslan M, Hallström BM, Lundbom J, Vergès B, Barrett PH, Watts GF, Serlie MJ, Nielsen J, Uhlén M, Smith U, Marschall HU, Taskinen MR, Boren J.

Mol Syst Biol. 2017 Mar 2;13(3):916. doi: 10.15252/msb.20167422.

10.

Recent explanatory trials of the mode of action of drug therapies on lipoprotein metabolism.

Chan DC, Barrett PH, Watts GF.

Curr Opin Lipidol. 2016 Dec;27(6):550-556. Review.

PMID:
27749370
11.

Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.

Chan DC, Pang J, Barrett PH, Sullivan DR, Mori TA, Burnett JR, van Bockxmeer FM, Watts GF.

Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1140-1145. doi: 10.1016/j.numecd.2016.07.012. Epub 2016 Aug 3.

PMID:
27614801
12.

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia.

Chan DC, Pang J, Barrett PH, Sullivan DR, Burnett JR, van Bockxmeer FM, Watts GF.

J Clin Endocrinol Metab. 2016 Oct;101(10):3732-3739. Epub 2016 Aug 4.

PMID:
27490922
13.

Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.

Ooi EM, Chan DC, Hodson L, Adiels M, Boren J, Karpe F, Fielding BA, Watts GF, Barrett PH.

Eur J Clin Invest. 2016 Aug;46(8):730-6. doi: 10.1111/eci.12657.

PMID:
27378472
14.

Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Diffenderfer MR, Lamon-Fava S, Marcovina SM, Barrett PH, Lel J, Dolnikowski GG, Berglund L, Schaefer EJ.

Metabolism. 2016 Apr;65(4):381-90. doi: 10.1016/j.metabol.2015.10.031. Epub 2015 Nov 6.

15.

Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote.

Hooper AJ, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PHR, van Bockxmeer FM, Burnett JR.

Clin Biochem. 2016 Jun;49(9):720-722. doi: 10.1016/j.clinbiochem.2016.02.008. Epub 2016 Feb 23.

PMID:
26916057
16.

Modeling the Male Reproductive Endocrine Axis: Potential Role for a Delay Mechanism in the Inhibitory Action of Gonadal Steroids on GnRH Pulse Frequency.

Ferasyi TR, Barrett PH, Blache D, Martin GB.

Endocrinology. 2016 May;157(5):2080-92. doi: 10.1210/en.2015-1913. Epub 2016 Feb 24.

PMID:
26910309
17.

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Aho S, Simoneau-Robin I, Taskinen MR.

J Clin Endocrinol Metab. 2016 Apr;101(4):1398-406. doi: 10.1210/jc.2015-3740. Epub 2016 Feb 2.

PMID:
26835543
18.

Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic Adults.

Chan DC, Pang J, McQuillan BM, Hung J, Beilby JP, Barrett PH, Watts GF.

Heart Lung Circ. 2016 May;25(5):520-5. doi: 10.1016/j.hlc.2015.10.017. Epub 2015 Nov 18.

PMID:
26706651
19.

Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes.

Pang J, Chan DC, Hamilton SJ, Tenneti VS, Watts GF, Barrett PH.

Diabetes Obes Metab. 2016 Apr;18(4):384-91. doi: 10.1111/dom.12622. Epub 2016 Jan 28.

PMID:
26679079
20.

Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.

Ooi EM, Watts GF, Chan DC, Pang J, Tenneti VS, Hamilton SJ, McCormick SP, Marcovina SM, Barrett PH.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2686-93. doi: 10.1161/ATVBAHA.115.306136. Epub 2015 Oct 29.

PMID:
26515419
21.

Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.

Hodson L, Banerjee R, Rial B, Arlt W, Adiels M, Boren J, Marinou K, Fisher C, Mostad IL, Stratton IM, Barrett PH, Chan DC, Watts GF, Harnden K, Karpe F, Fielding BA.

J Am Heart Assoc. 2015 Oct 2;4(10):e002258. doi: 10.1161/JAHA.115.002258.

22.

Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.

Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.

J Clin Endocrinol Metab. 2015 Nov;100(11):E1484-90. doi: 10.1210/jc.2015-2731. Epub 2015 Aug 31.

PMID:
26323024
23.

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.

Borén J, Watts GF, Adiels M, Söderlund S, Chan DC, Hakkarainen A, Lundbom N, Matikainen N, Kahri J, Vergès B, Barrett PH, Taskinen MR.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2218-24. doi: 10.1161/ATVBAHA.115.305614. Epub 2015 Aug 27. Erratum in: Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):e57.

PMID:
26315407
24.

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Ooi EM, Watts GF, Ng TW, Barrett PH.

Nutrients. 2015 Jun 2;7(6):4416-25. doi: 10.3390/nu7064416. Review.

25.

Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin Treatment.

Ng TW, Ooi EM, Watts GF, Chan DC, Meikle PJ, Barrett PH.

J Clin Endocrinol Metab. 2015 Jun;100(6):2497-501. doi: 10.1210/jc.2014-4348. Epub 2015 Mar 27.

PMID:
25816050
26.

Rosuvastatin Enhances the Catabolism of LDL apoB-100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner.

Le NA, Diffenderfer MR, Thongtang N, Ooi EM, Barrett PH, Horvath KV, Dolnikowski GG, Asztalos BF, Schaefer EJ, Brown WV.

Lipids. 2015 May;50(5):447-58. doi: 10.1007/s11745-015-4005-0. Epub 2015 Mar 26.

PMID:
25809021
27.
28.

Dose-dependent effects of rosuvastatin on the plasma sphingolipidome and phospholipidome in the metabolic syndrome.

Ng TW, Ooi EM, Watts GF, Chan DC, Weir JM, Meikle PJ, Barrett PH.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2335-40. doi: 10.1210/jc.2014-1665. Epub 2014 Aug 20.

PMID:
25140396
29.

Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Robin I, Taskinen MR.

J Clin Endocrinol Metab. 2014 Nov;99(11):4281-90. doi: 10.1210/jc.2014-2365. Epub 2014 Jul 31.

PMID:
25077901
30.

A novel ApoA-I truncation (ApoA-IMytilene) associated with decreased ApoA-I production.

Anthanont P, Polisecki E, Asztalos BF, Diffenderfer MR, Barrett PH, Millar JS, Billheimer J, Cuchel M, Rader DJ, Schaefer EJ.

Atherosclerosis. 2014 Aug;235(2):470-6. doi: 10.1016/j.atherosclerosis.2014.05.935. Epub 2014 Jun 2.

PMID:
24950002
31.

The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.

Chan DC, Barrett PH, Watts GF.

Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):369-85. doi: 10.1016/j.beem.2013.10.001. Epub 2013 Oct 9. Review.

PMID:
24840265
32.

Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.

Chan DC, Gan SK, Wong AT, Barrett PH, Watts GF.

Diabetes Obes Metab. 2014 Oct;16(10):994-1000. doi: 10.1111/dom.12311. Epub 2014 May 29.

PMID:
24821431
33.

Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial state.

Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1427-35. doi: 10.1210/jc.2013-4037. Epub 2014 Feb 27.

PMID:
24606094
34.

Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function.

Dickinson KM, Clifton PM, Burrell LM, Barrett PH, Keogh JB.

Atherosclerosis. 2014 Jan;232(1):211-6. doi: 10.1016/j.atherosclerosis.2013.10.032. Epub 2013 Nov 20.

PMID:
24401240
35.

Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.

Ng TW, Ooi EM, Watts GF, Chan DC, Barrett PH.

Diabetes Obes Metab. 2014 Jun;16(6):519-26. doi: 10.1111/dom.12243. Epub 2013 Dec 29.

PMID:
24299019
36.

Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.

Pang J, Chan DC, Hamilton SJ, Tenneti VS, Watts GF, Barrett PH.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):427-32. doi: 10.1161/ATVBAHA.113.302019. Epub 2013 Nov 27.

PMID:
24285582
37.

Plasma apolipoprotein B-48 transport in obese men: a new tracer kinetic study in the postprandial state.

Wong AT, Chan DC, Pang J, Watts GF, Barrett PH.

J Clin Endocrinol Metab. 2014 Jan;99(1):E122-6. doi: 10.1210/jc.2013-2477. Epub 2013 Dec 20.

PMID:
24203058
38.

The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.

Ooi EM, Barrett PH, Watts GF.

Int J Cardiol. 2013 Oct 3;168(3):1811-8. doi: 10.1016/j.ijcard.2013.06.069. Epub 2013 Jul 29.

PMID:
23907036
39.

Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.

Heeks LV, Hooper AJ, Adams LA, Robbins P, Barrett PH, van Bockxmeer FM, Burnett JR.

Clin Chim Acta. 2013 Jun 5;421:121-5. doi: 10.1016/j.cca.2013.03.004. Epub 2013 Mar 13.

PMID:
23694813
40.

Dietary fatty acids and lipoprotein metabolism: new insights and updates.

Ooi EM, Ng TW, Watts GF, Barrett PH.

Curr Opin Lipidol. 2013 Jun;24(3):192-7. doi: 10.1097/MOL.0b013e3283613ba2. Review.

PMID:
23619368
41.

Supplementation with n3 fatty acid ethyl esters increases large and small artery elasticity in obese adults on a weight loss diet.

Wong AT, Chan DC, Barrett PH, Adams LA, Watts GF.

J Nutr. 2013 Apr;143(4):437-41. doi: 10.3945/jn.112.169359. Epub 2013 Jan 30.

PMID:
23365106
42.

Omega-3 fatty acid ethyl ester supplementation decreases very-low-density lipoprotein triacylglycerol secretion in obese men.

Wong AT, Chan DC, Ooi EM, Ng TW, Watts GF, Barrett PH.

Clin Sci (Lond). 2013 Mar 13;125(1):45-51. doi: 10.1042/CS20120587.

PMID:
23356247
43.

Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome.

Ooi EM, Ng TW, Watts GF, Chan DC, Barrett PH.

J Lipid Res. 2012 Nov;53(11):2443-9. doi: 10.1194/jlr.P029223. Epub 2012 Aug 28.

44.

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects.

Ooi EM, Lichtenstein AH, Millar JS, Diffenderfer MR, Lamon-Fava S, Rasmussen H, Welty FK, Barrett PH, Schaefer EJ.

J Lipid Res. 2012 Sep;53(9):1958-67. doi: 10.1194/jlr.P024315. Epub 2012 Jul 6.

45.

Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.

Chan DC, Hoang A, Barrett PH, Wong AT, Nestel PJ, Sviridov D, Watts GF.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1658-66. doi: 10.1210/jc.2012-1522. Epub 2012 Jun 28.

PMID:
22745238
46.

Postprandial dyslipidaemia and diabetes: mechanistic and therapeutic aspects.

Pang J, Chan DC, Barrett PH, Watts GF.

Curr Opin Lipidol. 2012 Aug;23(4):303-9. doi: 10.1097/MOL.0b013e328354c790. Review.

PMID:
22595742
47.

Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism.

Diffenderfer MR, Brousseau ME, Millar JS, Barrett PH, Nartsupha C, Schaefer PM, Wolfe ML, Dolnikowski GG, Rader DJ, Schaefer EJ.

J Lipid Res. 2012 Jun;53(6):1190-9. doi: 10.1194/jlr.M019570. Epub 2012 Apr 2.

48.

Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations.

Ooi EM, Russell BS, Olson E, Sun SZ, Diffenderfer MR, Lichtenstein AH, Keilson L, Barrett PH, Schaefer EJ, Sprecher DL.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):459-66. doi: 10.1161/ATVBAHA.111.238493. Epub 2011 Nov 17.

49.

Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.

Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH.

J Clin Endocrinol Metab. 2011 Oct;96(10):E1568-76. doi: 10.1210/jc.2011-1131. Epub 2011 Aug 3.

PMID:
21816786
50.

Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese men.

Chan DC, Watts GF, Ooi EM, Chan DT, Wong AT, Barrett PH.

Metabolism. 2011 Oct;60(10):1482-7. doi: 10.1016/j.metabol.2011.03.003. Epub 2011 May 6.

PMID:
21550083

Supplemental Content

Loading ...
Support Center